Authors
Han Li, Sijia Hou, Wei Jiang
Published in
Autoimmunity reviews. Pages 104237. Nov 12, 2026. Epub Nov 12, 2026.
Abstract
Epstein-Barr virus (EBV) is a major environmental risk factor for multiple sclerosis (MS) and has also been linked-though with limited evidence-to other central nervous system (CNS) autoimmune diseases. The paradox of ubiquitous infection yet rare disease, along with fragmented hypotheses (molecular mimicry, Pender, Aloisi, driver, and hit-and-run hypotheses), highlights the need for a unifying model. Here, we propose a hypothetical "permissive-to-intrathecal activation model" in which genetic susceptibility, age at primary infection, and environmental exposures collectively lead to immune control failure of EBV-infected B cells (impaired immune surveillance and self-tolerance), allowing them to reprogram, migrate to the CNS, and become the central pathological hub, where intrathecal B-cell activation drives T-cell-mediated injury. Within this model, existing hypotheses can be integrated as specific components of this cascade. Based on the model, we outline three therapeutic strategies (primary prevention, EBV-directed, and B-cell-directed). Beyond MS, its core concepts-permissive conditions, immune control failure, and intrathecal activation-might provide a conceptual framework for other EBV-associated CNS autoimmune diseases, including neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A), despite limited epidemiological evidence. In this framework, disease-specific permissive conditions shape distinct patterns of immune control failure, which determines EBV's divergent roles, while intrathecal B-cell activation remains a shared process. This review may advance mechanistic understanding of EBV-driven CNS autoimmunity and provide a theoretical basis for precision intervention.
PMID:
43020364
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0